Atlas Trials

OE MRI to Predict Treatment Response After TACE in HCC Patients

Clinical trial NCT07617038 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07617038
Sponsor
Université de Montréal
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
HCC - Hepatocellular CarcinomaTACESIRT
Start date
2024-11-27
Primary completion
2027-12-20
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.